Anchorage-independent growth of p53-knockout dermal fibroblasts is reversed by wild-type p53

被引:3
作者
Bush, JA [1 ]
Li, G [1 ]
机构
[1] Univ British Columbia, Jack Bell Res Ctr, Div Dermatol, Dept Med, Vancouver, BC V6H 3Z6, Canada
关键词
D O I
10.1177/120347540100500105
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: p53 is a 393-residue nuclear phosphoprotein. Mutation of p53 occurs in over half of all human cancers and thus is a crucial step in the process of cell transformation and tumorigenesis. Since tumorigenesis is a multistep process, it generally requires the mutation of certain key oncogenes and/or tumor-suppressor genes. Using p53-deficient mice, we can investigate the p53-dependent mechanisms leading to tumorigenesis. Objective: To examine the unique anchorage-independent growth characteristics of dermal Fibroblasts isolated from p53-deficient mice. Methods: The growth characteristics of highly confluent cultured dermal Fibroblasts from wild-type (p53(-/-)) and p53-deficient (p53(-/-)) mice were compared by DNA fragmentation assay, colony formation in soft agar, and overexpression of a wild-type p53 transgene in p53-deficient cells. Results: p53(-/-) fibroblasts have a growth rate dramatically higher than p53(+/+) cells and detach from plastic cultureware at high density. The detachment of p53(-/-) cells is not due to apoptosis. Furthermore, these cells have the capacity to grow in soft agar-a hallmark of cell trans formation-and this anchorage-independent growth can be reversed by the introduction of a wild-type p53 transgene. Conclusion: Dermal fibroblasts isolated from p53-deficient mice show anchorage-independent growth. Therefore, the absence of p53 is sufficient for the initiation of cell transformation in this cell type and establishes this model system as an excellent tool to dissect the molecular steps involved in oncogenesis.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 52 条
[1]   p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints [J].
Agapova, LS ;
Ivanov, AV ;
Sablina, AA ;
Kopnin, PB ;
Sokova, OI ;
Chumakov, PM ;
Kopnin, BP .
ONCOGENE, 1999, 18 (20) :3135-3142
[2]  
Bögler O, 1999, CELL GROWTH DIFFER, V10, P73
[3]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[4]   GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE [J].
CHEN, PL ;
CHEN, YM ;
BOOKSTEIN, R ;
LEE, WH .
SCIENCE, 1990, 250 (4987) :1576-1580
[5]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[6]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[7]   p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53 [J].
Fang, L ;
Igarashi, M ;
Leung, J ;
Sugrue, MM ;
Lee, SW ;
Aaronson, SA .
ONCOGENE, 1999, 18 (18) :2789-2797
[8]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[9]   Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts [J].
Ford, JM ;
Hanawalt, PC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :28073-28080
[10]   DISRUPTION OF EPITHELIAL CELL-MATRIX INTERACTIONS INDUCES APOPTOSIS [J].
FRISCH, SM ;
FRANCIS, H .
JOURNAL OF CELL BIOLOGY, 1994, 124 (04) :619-626